Michael J. Baine - Concepedia

Author

Michael J. Baine

University of Nebraska Medical Center ORCID

Also Known As

Baine, Michael, Baine, Michael J, Baine, Michael J., M J Baine, M. Baine, MICHAEL J. BAINE, Michael Baine, Michael J Baine, Michael J. Baine, Ndulue, Jideofor K

138

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Nebraska Medical Center University of Nebraska–Lincoln The University of Texas MD Anderson Cancer Center University of Pennsylvania University of Pittsburgh

About

Michael J. Baine is an author at University of Nebraska Medical Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	535
2	Health Sciences	5	5	109
3	Engineering	2	2	75
4	Natural Sciences	1	1	30
5	Biochemistry	1	1	30

Michael J. Baine

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Journal of the National Comprehensive Cancer Network	2022	627
Marital Status and Survival in Pancreatic Cancer Patients: A SEER Based Analysis Michael J. Baine, Freshta Sahak, Chi Lin, PLoS ONE	2011	179
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024 Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Journal of the National Comprehensive Cancer Network Advanced RccNccn Guidelines® InsightsRadiation OncologyUrologySurgical Oncology	2024	127
Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility Michael J. Baine, Subhankar Chakraborty, Lynette M. Smith, PLoS ONE	2011	123
Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation Joshua J. Souchek, Michael J. Baine, Chien‐Yu Lin, British Journal of Cancer	2014	104
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy Satyanarayana Rachagani, María P. Torres, Sushil Kumar, Journal of Hematology & Oncology	2012	82
Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer Subhankar Chakraborty, Michael J. Baine, Kavita Mallya, PLoS ONE Biomarker (Medicine)Prognostic BiomarkersPancreatic CancerLethal Pancreatic CancerMedicine	2013	63
Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy Elsa Parr, Qian Du, Chi Zhang, Cancers Adaptive RadiotherapyRadiomics-based Outcome PredictionSurgical OncologyPancreatic CancerMedical Imaging	2020	56
Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer Michael J. Baine, Vivek Verma, Caitlin A. Schonewolf, Lung Cancer MedicineCancer RecurrencePathologyBronchial NeoplasmPulmonary Blastoma	2018	52
Percentage of Hormone Receptor Positivity in Breast Cancer Provides Prognostic Value: A Single-Institute Study Richard Sleightholm, Beth K. Neilsen, Safwan Elkhatib, Journal of Clinical Medicine Research	2021	52

Page 1